• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Initial Introduction and Spread of the SARS-CoV-2 AY.4.2.1 Delta Variant in Bulgaria, a Genomic Insight

tetano

Editor, Senior Moderator
J Med Virol


. 2022 Jul 28.
doi: 10.1002/jmv.28033. Online ahead of print.
Initial Introduction and Spread of the SARS-CoV-2 AY.4.2.1 Delta Variant in Bulgaria, a Genomic Insight


Ivailo Alexiev[SUP] 1 [/SUP], Marta Giovanetti[SUP] 2 [/SUP], Eleonora Cella[SUP] 3 [/SUP], Ivan Ivanov[SUP] 1 [/SUP], Ivan Stoikov[SUP] 1 [/SUP], Deyan Donchev[SUP] 1 [/SUP], Lubomira Grigorova[SUP] 1 [/SUP], Anna Gancheva[SUP] 1 [/SUP], Reneta Dimitrova[SUP] 1 [/SUP], Nelly Korsun[SUP] 1 [/SUP], Ivelina Trifonova[SUP] 1 [/SUP], Ivva Philipova[SUP] 1 [/SUP], Veselin Dobrinov[SUP] 1 [/SUP], Iliana Grigorova[SUP] 1 [/SUP], Todor Kantardjiev[SUP] 1 [/SUP], Iva Christova[SUP] 1 [/SUP], Massimo Ciccozzi[SUP] 4 [/SUP]



Affiliations

Abstract

The evolution of the emerging SARS-CoV-2 variants carrying mutations in the spike protein raises concerns about the possibility of accelerated transmission in the ever-evolving COVID-19 pandemic worldwide. AY.4.2, a sublineage of the Delta variant, was considered a variant under investigation (VUI) and also gained the nickname 'Delta Plus', due to its extra mutations, Y145H and A222V. In this study, using genomic epidemiology, we provide the first insights of the introduction of AY.4.2 in Bulgaria and the AY.4.2.1 sublineage that found larger dissemination only in Bulgaria and the United Kingdom. This article is protected by copyright. All rights reserved.

Keywords: Evolution, Epidemiology; SARS coronavirus; Virus classification, Mutation/Mutation rate.
 
Back
Top Bottom